Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000769993-04-000129
Filing Date
2004-02-12
Accepted
2004-02-12 15:36:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 2003 YEAR-END 13G AMENDMENT NUMBER 1 UTHR unitedtherapeuticscorp1.txt SC 13G/A 10053
  Complete submission text file 0000769993-04-000129.txt   12095
Mailing Address 85 BROAD ST NEW YORK NY 10004
Business Address 85 BROAD ST NEW YORK NY 10004 2129021000
GOLDMAN SACHS GROUP INC/ (Filed by) CIK: 0000886982 (see all company filings)

EIN.: 134019460 | State of Incorp.: DE | Fiscal Year End: 1128
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 1110 SPRING ST SILVER SPRING MD 20910
Business Address 1110 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS CORP (Subject) CIK: 0001082554 (see all company filings)

EIN.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-57843 | Film No.: 04591362
SIC: 2834 Pharmaceutical Preparations